- Recent trends in the treatment of chronic hepatitis C
-
Jun DW, Tak WY, Bae SH, Lee YJ
- KMID: 1372647
- Korean J Hepatol.
- 2012 Mar;18(1):22-28.
- doi: 10.3350/kjhep.2012.18.1.22
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatment for chronic hepatitis C regardless of HCV genotype. This combination therapy achieves higher response rates than previous... -
- CITED
-
- Close
- SHARE
-
- Close
- The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
-
Varbobitis I, Papatheodoridis GV
- KMID: 2373131
- Clin Mol Hepatol.
- 2016 Sep;22(3):319-326.
- doi: 10.3350/cmh.2016.0045
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting... -
- CITED
-
- Close
- SHARE
-
- Close
